DiscoverWSJ What’s NewsFDA Analysis of J&J's Single-Dose Covid-19 Vaccine Expected Today
FDA Analysis of J&J's Single-Dose Covid-19 Vaccine Expected Today

FDA Analysis of J&J's Single-Dose Covid-19 Vaccine Expected Today

Update: 2021-02-24
Share

Description

A.M. Edition for Feb. 24. Today's release is a key step toward emergency authorization. WSJ's Jared Hopkins discusses the unusual alliances among drugmakers during the pandemic. WSJ's Mike Bird looks at the recent decline in the cryptocurrency market. Marc Stewart hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

FDA Analysis of J&J's Single-Dose Covid-19 Vaccine Expected Today

FDA Analysis of J&J's Single-Dose Covid-19 Vaccine Expected Today

The Wall Street Journal